Acquisition of Nostos Genomics by Limbus
Basel / Berlin / Rostock, September 2025 – Hoffmann & Partner is pleased to announce that it has advised the shareholders of Nostos Genomics GmbH (“Nostos”) as M&A advisors in the successful acquisition by Limbus Medical Technologies GmbH (“Limbus”). Two...
Fit for sale: How to make your company attractive to successors and buyers
For many entrepreneurs, selling their own company is the crowning glory of a lifetime of business – but also one of the biggest challenges.Successful business succession does not begin with the search for a successor or buyer, but with forward-looking preparation....
Webinar by Luminance Health on Tuesday, 9 September: Hoffmann & Partner are part of the expert panel
Are you planning to launch medicinal products in Europe? The Luminance Health webinar is designed to equip life science professionals with the insights and tools needed for a successful European launch. Discover how combining expertise in regulatory affairs, quality...
MaserGrup has made a strategic investment in Holle baby food
MaserGrup has made a strategic investment in Holle baby food, a Swiss pioneer in organic and biodynamic infant nutrition, as part of its international expansion into high-value, sustainable food categories. Holle baby food AG, founded in 1934 in Arlesheim...
Buy-side due diligence – targeted, precise, cost-efficient
Buy-side transactions are not a game of chance. They are based on analysis.In acquisition processes, investment decisions often have to be made under time pressure – with simultaneous information asymmetry between seller and buyer. Those who fail to ask the right...
Healthcare M&A trends in the DACH region – 2021 to 2024
This newsletter provides a comprehensive overview of M&A activity in the healthcare industry across the DACH region, with a particular focus on Switzerland. The analysis covers transactions from 2021 to 2024. At a glance: After a multi-year decline, healthcare...
Basel-based energy service provider IWB acquires solar system specialist Senero AG
The Basel-based energy service provider IWB is taking over the solar plant specialist Senero AG. In line with its strategy, IWB intends to further accelerate its growth with renewable energies in Switzerland. Senero is gaining support in the rapidly growing national...
New partnership: (interim) financial management & personnel services from a single source – Hoffmann & Partner AG & Basel Job
We are pleased to announce a new co-operation agreement with Basel Job. This partnership brings together two experienced service providers - with one goal: to provide highly qualified interim financial expertise quickly, flexibly and precisely and to fill a vacancy...
CFO-services for the life sciences industry
Patrick Schacher, CFO Partner, had the opportunity to speak with Dr Paul Senn, CEO of Galvita, about their collaboration at our stand at the Swiss Biotech Days. Galvita AG, based in Basel, specialises in the production of microcapsules (Templated Inverted Particles /...
A positive summary of Swiss Biotech Days
The Swiss Biotech Days, the global biotech conference for life science professionals, took place at the Congress Center Basel from 5-6 May. We attended for the second time and for our team on site it was once again a great opportunity to meet visitors and other...